Tirupati Forge Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 7, 2025, 5:57 pm

Competitors of Tirupati Forge Ltd

All Competitor Stocks of Tirupati Forge Ltd

Quarterly Result

Last Updated: August 20, 2025, 2:10 am

Below is a detailed analysis of the quarterly data for Tirupati Forge Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 32.30 Cr.. The value appears strong and on an upward trend. It has increased from 27.50 Cr. (Mar 2025) to 32.30 Cr., marking an increase of 4.80 Cr..
• For Expenses, as of Jun 2025, the value is 28.62 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 24.40 Cr. (Mar 2025) to 28.62 Cr., marking an increase of 4.22 Cr..
• For Operating Profit, as of Jun 2025, the value is 3.68 Cr.. The value appears strong and on an upward trend. It has increased from 3.10 Cr. (Mar 2025) to 3.68 Cr., marking an increase of 0.58 Cr..
• For OPM %, as of Jun 2025, the value is 11.39%. The value appears strong and on an upward trend. It has increased from 11.27% (Mar 2025) to 11.39%, marking an increase of 0.12%.
• For Other Income, as of Jun 2025, the value is 0.62 Cr.. The value appears strong and on an upward trend. It has increased from 0.43 Cr. (Mar 2025) to 0.62 Cr., marking an increase of 0.19 Cr..
• For Interest, as of Jun 2025, the value is 0.73 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.44 Cr. (Mar 2025) to 0.73 Cr., marking an increase of 0.29 Cr..
• For Depreciation, as of Jun 2025, the value is 1.67 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.39 Cr. (Mar 2025) to 1.67 Cr., marking an increase of 0.28 Cr..
• For Profit before tax, as of Jun 2025, the value is 1.90 Cr.. The value appears strong and on an upward trend. It has increased from 1.70 Cr. (Mar 2025) to 1.90 Cr., marking an increase of 0.20 Cr..
• For Tax %, as of Jun 2025, the value is 25.79%. The value appears to be increasing, which may not be favorable. It has increased from 24.12% (Mar 2025) to 25.79%, marking an increase of 1.67%.
• For Net Profit, as of Jun 2025, the value is 1.41 Cr.. The value appears strong and on an upward trend. It has increased from 1.30 Cr. (Mar 2025) to 1.41 Cr., marking an increase of 0.11 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.12. The value appears strong and on an upward trend. It has increased from 0.11 (Mar 2025) to 0.12, marking an increase of 0.01.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:15 am

Growth

Last Updated: September 5, 2025, 1:46 pm

Balance Sheet

Last Updated: June 16, 2025, 11:11 am

Below is a detailed analysis of the balance sheet data for Tirupati Forge Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 24.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to 24.00 Cr., marking an increase of 3.00 Cr..
• For Reserves, as of Mar 2025, the value is 83.00 Cr.. The value appears strong and on an upward trend. It has increased from 29.00 Cr. (Mar 2024) to 83.00 Cr., marking an increase of 54.00 Cr..
• For Borrowings, as of Mar 2025, the value is 26.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 13.00 Cr. (Mar 2024) to 26.00 Cr., marking an increase of 13.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 13.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Mar 2024) to 13.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 146.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 74.00 Cr. (Mar 2024) to 146.00 Cr., marking an increase of 72.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 37.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2024) to 37.00 Cr., marking an increase of 18.00 Cr..
• For CWIP, as of Mar 2025, the value is 18.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 18.00 Cr., marking an increase of 10.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 90.00 Cr.. The value appears strong and on an upward trend. It has increased from 47.00 Cr. (Mar 2024) to 90.00 Cr., marking an increase of 43.00 Cr..
• For Total Assets, as of Mar 2025, the value is 146.00 Cr.. The value appears strong and on an upward trend. It has increased from 74.00 Cr. (Mar 2024) to 146.00 Cr., marking an increase of 72.00 Cr..

Notably, the Reserves (83.00 Cr.) exceed the Borrowings (26.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Tirupati Forge Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.74. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 0.74, marking an increase of 0.07.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.73. This value is below the healthy minimum of 5. It has increased from 0.67 (Mar 24) to 0.73, marking an increase of 0.06.
• For Cash EPS (Rs.), as of Mar 25, the value is 1.03. This value is below the healthy minimum of 3. It has increased from 0.97 (Mar 24) to 1.03, marking an increase of 0.06.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.05. It has increased from 4.81 (Mar 24) to 9.05, marking an increase of 4.24.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 9.05. It has increased from 4.81 (Mar 24) to 9.05, marking an increase of 4.24.
• For Dividend / Share (Rs.), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 9.72. It has decreased from 10.61 (Mar 24) to 9.72, marking a decrease of 0.89.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.40. This value is below the healthy minimum of 2. It has increased from 1.32 (Mar 24) to 1.40, marking an increase of 0.08.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.03. This value is within the healthy range. It has increased from 0.98 (Mar 24) to 1.03, marking an increase of 0.05.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.88. This value is within the healthy range. It has increased from 0.86 (Mar 24) to 0.88, marking an increase of 0.02.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 2. It has increased from 0.64 (Mar 24) to 0.66, marking an increase of 0.02.
• For PBDIT Margin (%), as of Mar 25, the value is 14.37. This value is within the healthy range. It has increased from 12.45 (Mar 24) to 14.37, marking an increase of 1.92.
• For PBIT Margin (%), as of Mar 25, the value is 10.57. This value is within the healthy range. It has increased from 9.31 (Mar 24) to 10.57, marking an increase of 1.26.
• For PBT Margin (%), as of Mar 25, the value is 9.14. This value is below the healthy minimum of 10. It has increased from 8.12 (Mar 24) to 9.14, marking an increase of 1.02.
• For Net Profit Margin (%), as of Mar 25, the value is 6.83. This value is within the healthy range. It has increased from 6.03 (Mar 24) to 6.83, marking an increase of 0.80.
• For Return on Networth / Equity (%), as of Mar 25, the value is 7.33. This value is below the healthy minimum of 15. It has decreased from 13.30 (Mar 24) to 7.33, marking a decrease of 5.97.
• For Return on Capital Employeed (%), as of Mar 25, the value is 9.83. This value is below the healthy minimum of 10. It has decreased from 19.14 (Mar 24) to 9.83, marking a decrease of 9.31.
• For Return On Assets (%), as of Mar 25, the value is 5.38. This value is within the healthy range. It has decreased from 8.93 (Mar 24) to 5.38, marking a decrease of 3.55.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.08. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.16. This value is within the healthy range. It has decreased from 0.22 (Mar 24) to 0.16, marking a decrease of 0.06.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.04. It has decreased from 1.75 (Mar 24) to 1.04, marking a decrease of 0.71.
• For Current Ratio (X), as of Mar 25, the value is 3.99. This value exceeds the healthy maximum of 3. It has increased from 2.22 (Mar 24) to 3.99, marking an increase of 1.77.
• For Quick Ratio (X), as of Mar 25, the value is 2.95. This value exceeds the healthy maximum of 2. It has increased from 1.14 (Mar 24) to 2.95, marking an increase of 1.81.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.71. This value is below the healthy minimum of 4. It has decreased from 3.41 (Mar 24) to 2.71, marking a decrease of 0.70.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 10.05. This value is within the healthy range. It has decreased from 10.44 (Mar 24) to 10.05, marking a decrease of 0.39.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.77. This value is within the healthy range. It has decreased from 6.06 (Mar 24) to 5.77, marking a decrease of 0.29.
• For Enterprise Value (Cr.), as of Mar 25, the value is 363.99. It has increased from 174.02 (Mar 24) to 363.99, marking an increase of 189.97.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.17. This value exceeds the healthy maximum of 3. It has increased from 1.58 (Mar 24) to 3.17, marking an increase of 1.59.
• For EV / EBITDA (X), as of Mar 25, the value is 22.02. This value exceeds the healthy maximum of 15. It has increased from 12.70 (Mar 24) to 22.02, marking an increase of 9.32.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 1.52 (Mar 24) to 3.30, marking an increase of 1.78.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Price / BV (X), as of Mar 25, the value is 3.54. This value exceeds the healthy maximum of 3. It has increased from 3.35 (Mar 24) to 3.54, marking an increase of 0.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.30. This value exceeds the healthy maximum of 3. It has increased from 1.52 (Mar 24) to 3.30, marking an increase of 1.78.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.02, marking a decrease of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness